Skip to main content

Cesarean Section Complications

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Raydiant Oximetry
Raydiant OximetryCA - San Ramon
1 program
DAISY Uterine DrainN/A1 trial
Active Trials
NCT06219538Completed10Est. Apr 2025
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Empowered ReliefN/A1 trial
Active Trials
NCT07192718Enrolling By Invitation60Est. Dec 2026

Trial Timeline

Clinical trial activity over time

2024
2025
2026
Human BioSciencesEmpowered Relief
Raydiant OximetryDAISY Uterine Drain

Clinical Trials (2)

Total enrollment: 70 patients across 2 trials

Using Empowered Relief and Education To Help Postpartum Women Recover After Cesarean Delivery

Start: Dec 2025Est. completion: Dec 202660 patients
N/AEnrolling By Invitation
NCT06219538Raydiant OximetryDAISY Uterine Drain

DAISY Uterine Drain Device Evaluation

Start: May 2024Est. completion: Apr 202510 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.